Priya Singhal - 01 Feb 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Development
Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal
Issuer symbol
BIIB
Transactions as of
01 Feb 2023
Net transactions value
$0
Form type
4
Filing time
03 Feb 2023, 17:35:25 UTC
Previous filing
27 Jan 2023
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIIB Common Stock 2,652 01 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +5,485 $0.000000 5,485 01 Feb 2023 Common Stock 5,485 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on February 1, 2023 and will vest in three equal installments on each anniversary of the grant date.